Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Damages return to haunt Boston in Johnson & Johnson patent case

This article was originally published in Clinica

Executive Summary

A Delaware Jury has found that Boston Scientific's NIR stent - which the company no longer sells - infringes Johnson & Johnson's Palmaz patent. No monetary damages have yet been set. Further post-verdict motions and hearings and an appeal by Boston Scientific are also expected. The verdict followed a retrial of earlier litigation in which J&J was awarded damages of $324m in 2000.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT054689

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel